Your browser doesn't support javascript.
loading
Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers.
O'Halloran, Philip J; Viel, Thomas; Murray, David W; Wachsmuth, Lydia; Schwegmann, Katrin; Wagner, Stefan; Kopka, Klaus; Jarzabek, Monika A; Dicker, Patrick; Hermann, Sven; Faber, Cornelius; Klasen, Tim; Schäfers, Michael; O'Brien, David; Prehn, Jochen H M; Jacobs, Andreas H; Byrne, Annette T.
Afiliação
  • O'Halloran PJ; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin 2, Ireland.
  • Viel T; National Neurosurgical Department, Beaumont Hospital, Dublin 9, Ireland.
  • Murray DW; European Institute for Molecular Imaging (EIMI), Westfälische Wilhelms-Universität (WWU) Münster, Münster, Germany.
  • Wachsmuth L; PARCC, INSERM U970, Université Paris Descartes, Paris, France.
  • Schwegmann K; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin 2, Ireland.
  • Wagner S; Department of Clinical Radiology, University Hospital Münster, Münster, Germany.
  • Kopka K; European Institute for Molecular Imaging (EIMI), Westfälische Wilhelms-Universität (WWU) Münster, Münster, Germany.
  • Jarzabek MA; Department of Nuclear Medicine, Münster University Hospital, Münster, Germany.
  • Dicker P; Department of Nuclear Medicine, Münster University Hospital, Münster, Germany.
  • Hermann S; Radiopharmaceutical Chemistry, German Cancer Research Centre (dkfz), Heidelberg, Germany.
  • Faber C; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin 2, Ireland.
  • Klasen T; Department of Epidemiology & Public Health, Royal College of Surgeons, Dublin 2, Ireland.
  • Schäfers M; European Institute for Molecular Imaging (EIMI), Westfälische Wilhelms-Universität (WWU) Münster, Münster, Germany.
  • O'Brien D; Department of Clinical Radiology, University Hospital Münster, Münster, Germany.
  • Prehn JH; Department of Clinical Radiology, University Hospital Münster, Münster, Germany.
  • Jacobs AH; European Institute for Molecular Imaging (EIMI), Westfälische Wilhelms-Universität (WWU) Münster, Münster, Germany.
  • Byrne AT; Department of Nuclear Medicine, Münster University Hospital, Münster, Germany.
Eur J Nucl Med Mol Imaging ; 43(9): 1673-83, 2016 Aug.
Article em En | MEDLINE | ID: mdl-26975402
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Imageamento por Ressonância Magnética / Glioblastoma / Tomografia por Emissão de Pósitrons / Serina-Treonina Quinases TOR / Bevacizumab / Inibidores de Fosfoinositídeo-3 Quinase / Imidazóis Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Assunto da revista: MEDICINA NUCLEAR Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Irlanda País de publicação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Imageamento por Ressonância Magnética / Glioblastoma / Tomografia por Emissão de Pósitrons / Serina-Treonina Quinases TOR / Bevacizumab / Inibidores de Fosfoinositídeo-3 Quinase / Imidazóis Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Assunto da revista: MEDICINA NUCLEAR Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Irlanda País de publicação: Alemanha